The role of endogenous calcitonin gene-related peptide (CGRP) in the nonadrenergic noncholinergic depressor response to spinal cord stimulation was studied in the pithed rat in vivo. Pithed rats were given hexamethonium (2 mg/kg per minute i.v.) to block autonomic outflow, and mean blood pressure was artificially maintained at approximately 100 mm Hg with methoxamine (10-15 ,ug/kg per minute i.v.). Electrical stimulation of the spinal cord at the level of the lower thoracic vertebra (T9-12) caused a fall in blood pressure in a frequency-dependent (0.5-10 Hz), voltage-dependent (2.5-50 V), and pulse duration-dependent (0.25-8 msec) manner. The heart rate did not change during the depressor response. 
TNhe tone of peripheral resistance blood vessels is mainly regulated by sympathetic adrenergic nerves through release of the neurotransmitter norepinephrine. However, nonadrenergic nerves innervate regional vascular beds, and nonadrenergic vasodilation is observed in various species.' The exact nature of the neurotransmitter substance of nonadrenergic nerves is not fully determined. Recent in vitro studies have shown that perivascular nerve stimulation of the perfused rat mesenteric vascular bed causes neurogenic vasodilation, which is mediated by nonadrenergic noncholinergic (NANC) nerves.2, 3 The peptidergic and sensory neurotoxin capsaicin, which depletes calcitonin gene-related peptide (CGRP) and substance P from nonadrenergic noncholinergic depressor response perivascular nerves,4-6 abolishes NANC vasodilation. 2, 3 In addition, perivascular nerve stimulation causes the tetrodotoxin-sensitive release of CGRP associated with the vasodilation.78 Therefore, we proposed that CGRP is a potential neurotransmitter for NANC vasodilation of mesenteric resistance blood vessels.2 More recent studies with a specific CGRP receptor antagonist (CGRP ), CGRP receptor desensitization, and antiserum against CGRP have confirmed that the NANC vasodilation in the rat mesenteric vascular bed is mediated by endogenous CGRP, probably released from CGRP-containing vasodilator nerve terminals.9"10 CGRP, a 37 amino acid peptide translated from the calcitonin gene," is a potent vasodilator12'13 and is widely distributed in perivascular nerves throughout the vascular system.14"5 The distribution and vascular activity of CGRP may indicate that it is an important endogenous neurotransmitter for neural regulation of the cardiovascular system. However, the role of CGRPcontaining nerves in cardiovascular regulation in vivo remains unknown. Therefore, the present study was designed to investigate 1) whether NANC vasodilation in vivo is elicited by spinal cord stimulation in the rat and 2) the possibility that CGRP is an endogenous neurotransmitter that mediates NANC vasodilation. To achieve these aims, we used pithed rats with artificially increased blood pressure (BP) and with the autonomic outflow blocked.
Materials and Methods

Animals
Male Wistar rats, weighing 360-420 g, were used in this study. The 
Spinal Cord Stimulation
After allowing BP and HR to stabilize, electrical stimulation (rectangular pulses at 10 V, 1-msec pulse duration) was applied to verify the position of the rod in the spinal column. Then, mean BP was increased and maintained at a level of approximately 100 mm Hg by continuous infusion of the ar-adrenoceptor agonist methoxamine (10) (11) (12) (13) (14) (15) 
Capsaicin Treatment
The animals were anesthetized with halothane and were treated with 1 mg/kg i.p. atropine, and then they were injected subcutaneously with 100 mg/kg capsaicin or an equal volume of solvent (50% ethanol in 0.9% saline) on the first day; the capsaicin was given in four injections (5, 15, 30 , and 50 mg/kg) at 3-hour intervals. On the two following consecutive days they were treated with doses of 200 mg/kg per day capsaicin (four injections of 50 mg/kg s.c. at 3-hour intervals), giving a total dosage of 500 mg/kg, or with an equal volume of solvent, according to the method described by Jessel et al. 18 Five days after the last injection, the animals were subjected to pithing.
Statistical Analysis
The experimental results are expressed as mean± SEM. Statistical significance was determined by oneway analysis of variance followed by Dunnett's test. A value of p<0.05 was considered statistically significant.
Drugs
The following drugs were used: acetylcholine chloride (Daiichi Pharmaceutical Co., Tokyo), atropine sulfate (Sigma Chemical Co., St. Louis, Mo.), capsaicin (Sigma), cimetidine (Sigma), guanethidine sulfate (Tokyo Kasei, Tokyo), hexamethonium bromide (Sigma), histamine dihydrochloride (Wako Junyaku, Osaka, Japan), human CGRP (Peptide Institute, Osaka, Japan), l-isoproterenol hydrochloride (Sigma), propranolol hydrochloride (Sigma), pyrilamine maleate (Sigma), rat CGRP (Peptide Institute), substance P (Peptide Institute), and tetrodotoxin (Sigma). Capsaicin was dissolved in 50% ethanol in 0.9% saline and injected subcutaneously. All other drugs were dissolved in 0.9% saline and infused at a rate of 0.3 ml/hr using an infusion pump (model 11, Harvard Apparatus) or were given as bolus doses (0.2 ml/kg).
Results
Cardiovascular Responses to Spinal Cord Stimulation
Electrical stimulation of the higher thoracic region (T1-4) evoked a sharp rise in BP and an increase in HR ( Figure 1A ). Stimulation (2) (3) (4) (5) (6) (7) (8) of the lower thoracic region (T9-12) evoked a frequency-dependent increase in BP without alteration of HR ( Figure 1B ). Therefore, in the following experiments the lower thoracic region (T9-12) was stimulated to minimize the cardiac effect on vascular responses. As shown in Figure 1B , pressor responses to spinal cord stimulation were completely inhibited by the autonomic ganglionic blocker hexamethonium (2 mg/kg per minute i.v.). The pressor responses were also abolished by the neurotoxin tetrodotoxin (100 ,ug/kg i.v.) and by the adrenergic neuron blocker guanethidine ( caused a small fall in BP after autonomic outflow was blocked with hexamethonium, as shown in Figure 1C .
Depressor Response to Spinal Cord Stimulation
The mean BP of pithed rats was artificially increased and maintained at approximately 100 mm Hg by continuous infusion of methoxamine (10-15 jig/kg per minute i.v.) in the presence of hexamethonium (2 mg/kg per minute i.v.). As shown in Figure 1C , electrical stimulation (10 V, 1-msec duration) of the lower thoracic region (T9-12) produced a frequency-dependent fall in BP. This depressor response appeared 10-20 seconds after the stimulation began and reached a maximum at 1-2 minutes after the stimulation ended, and BP returned to the prestimulation level within 5-15 minutes in the case of higher frequencies (4) (5) (6) (7) (8) . The Figure 6 shows the depressor responses to various vasodilators and to spinal cord stimulation in the pithed rat with artificially increased BP. As shown in Figure  6A , spinal cord stimulation caused a frequency-dependent and long-lasting fall in BP without changes in HR. Bolus injection of rat CGRP (0.1 nmol/kg i.v.) also caused a long-lasting fall in BP without changes in HR, which mimicked the depressor response to spinal cord stimulation. However, bolus injections of acetylcholine (1 nmol/kg i.v.), substance P (0.3 nmol/kg i.v.), isoproterenol (1 nmol/kg i.v.), and histamine (0.3 nmol/kg i.v.) induced a sharp and transient fall in BP (Figures 6B and  6C) . Injection of isoproterenol, but not acetylcholine, substance P, or histamine, increased HR.
Effect of Capsaicin Treatment
As shown in Figure 7 , spinal cord stimulation in vehicle-treated pithed rats caused a frequency-dependent depressor response. In pithed rats treated with capsaicin (total doses of 500 mg/kg s.c.), depressor responses to spinal cord stimulation were significantly smaller than in vehicle-treated pithed rats.
Effect of CGRP [8-3 7] , a CGRP Receptor Antagonist
As shown in Figure 8A , both spinal cord stimulation and bolus injection of rat CGRP caused a long-lasting fall in BP without changes in HR, whereas bolus injection of isoproterenol induced a transient fall in BP concomitant with an increase in HR. Continuous infusion of human CGRP the depressor responses to spinal cord stimulation and to rat CGRP returned to the levels measured before infusion of the antagonist ( Figure 8C ). However, neither the depressor response nor the increase in HR caused by isoproterenol was affected by human CGRP (Figure 8B ). Figure 9 summarizes the changes in depressor responses induced by spinal cord stimulation (2 and 4 Hz), exogenous rat CGRP, and isoproterenol before, during, and after infusion of human CGRP . Discussion The pithed rat preparation has been used to study cardiovascular changes mediated by autonomic outflow from the spinal cord in vivo.16,17 Previous reports16"17 and the present study show that electrical stimulation of the thoracolumbar spinal cord in the pithed rat increases the pressor response with little change in HR. Since this response can be attenuated by an autonomic ganglionic blocker (hexamethonium), an adrenergic neuron blocker (guanethidine), and an a-adrenoceptor antagonist (phentolamine),17 the response results from vasoconstriction mediated by norepinephrine that is released in response to preganglionic stimulation of sible for the depressor response to spinal cord stimulation. Endogenous histamine has also been proposed to be involved in the neurogenic vasodilation of the skin and hind leg, because the vasodilation is inhibited by the histamine receptor antagonist, especially by histamine H2-receptor antagonist, and is also sensitive to the autonomic ganglionic blocker.1''9-22 However, the present findings show that the depressor response to spinal cord stimulation is not sensitive to the histamine Hland H2-receptor antagonist. Thus, involvement of endogenous histamine in the NANC depressor response to spinal cord stimulation is unlikely. Furthermore, the present study shows that the depressor response to spinal cord stimulation is long lasting and that this differs from the responses to a 13- inhibits both the vasodilation caused by exogenous CGRP and by perivascular nerve stimulation in the perfused mesenteric vascular bed.9 An in vivo study using conscious and pentobarbital-anesthetized rats also showed that human CGRP antagonizes the hypotensive response to exogenous CGRP.2930 In addition, the selectivity of human CGRP has been confirmed by the finding that it has no effect on the vasodilator response to bradykinin, histamine, isoproterenol, or substance p.9,30 In the present study, human CGRP markedly inhibited the depressor responses to spinal cord stimulation and to exogenous rat CGRP but not to isoproterenol. This finding strongly suggests that the NANC depressor response is mediated by endogenous CGRP, which is probably released from capsaicin-sensitive and CGRP-containing nerve terminals by spinal cord stimulation. Direct electrical stimulation of the dorsal spinal column and of the peripheral part of cut dorsal roots or sensory nerves (saphenous nerves or trigeminal nerves) has been shown to result in vasodilation in the skin and skeletal muscle area supplied by these nerves.31-34 It is well known that this vasodilation is produced by antidromic conduction in sensory nerves. The depressor response to spinal cord stimulation is sensitive to capsaicin, and CGRP is contained in capsaicin-sensitive sensory nerves. Therefore, the spinal cord stimulationinduced depressor response may result from antidromic conduction of sensory afferent nerves. This conduction may cause the release of CGRP from distal terminals of sensory nerves, which bifurcate from the sensory nerves.35 However, many studies have shown that antidromic stimulation does not change the systemic blood pressure and that the regional vasodilation produced is sensitive to atropine, histamine antagonists, and indomethacin.31-34 Such results are not consistent with the present findings that stimulation of a limited spinal segment (T9-12) can cause a systemic depressor response that is insensitive to atropine and to histamine antagonists. Therefore, we hypothesize that there is outflow of CGRP-containing vasodilator nerves from the spinal cord to blood vessels. Further experiments are needed to test this hypothesis.
In conclusion, the present study demonstrates that spinal cord stimulation results in a neurogenic depressor response, which is mediated by NANC vasodilator nerves. Endogenous CGRP is the most likely mediator of this vasodilation and is probably released from capsaicin-sensitive nerve terminals by electrical stimulation of the spinal cord. The present report is the first to provide in vivo evidence that endogenous CGRP acts as a neurotransmitter that mediates NANC vasodilation. The present results also suggest that CGRP-containing vasodilator nerves play a role in neuronal control of the tone of resistance blood vessels.
